Investing

Jupiter Wellness Seeks New Prescription Products For Issues In Breast Cancer Patients – Jupiter Wellness (NASDAQ:JUPW)

ByShivani Kumaresan

Sep 20, 2022
Jupiter Wellness Seeks New Prescription Products For Issues In Breast Cancer Patients - Jupiter Wellness (NASDAQ:JUPW)

[ad_1]

  • Jupiter Wellness Inc JUPW has signed an exclusive licensing agreement with Rejoy Inc to develop prescription products for the treatment of nipple neuropathies for breast cancer patients.

  • The exclusive license includes issued patents and technology, including formulations.

  • Related: Jupiter Wellness Registers 400% Jump In Q2 Revenue

  • In clinical studies, one topical formulation improved nipple sensitivity and alleviated associated sexual problems. 

  • The product has been named JW-500 to be added to a line of other clinical stage products currently under development.

  • Jupiter Wellness plans to file for a pre-IND meeting with the FDA within the next 12 months and intends to seek Orphan Drug Designation.

  • Price Action: JUPW shares are trading higher by 1.63% at $1.05 on the last check Tuesday.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

[ad_2]

Image and article originally from www.benzinga.com. Read the original article here.

By Shivani Kumaresan

Related Post

Investing

Average long-term US mortgage rate lowest since September

Jan 19, 2023 The Associated Press
Investing

IoT News – Digital Healthcare

Jan 19, 2023 IoT.Business.News
Investing

Take On One Thing and Beat It Into Submission

Jan 19, 2023 Tom Corley

You missed

Stocks

Costco Stock Is Moving Higher After Hours: What’s Going On?

Jan 19, 2023 Adam Eckert
Investing

Average long-term US mortgage rate lowest since September

Jan 19, 2023 The Associated Press
Stocks

Vice Media restarts sale process at lower valuation

Jan 19, 2023 admin
Investing

IoT News – Digital Healthcare

Jan 19, 2023 IoT.Business.News